top of page

CRB1

Disease Category: autosomal recessive

Patient Population: unknown

Known Clinical Trials: 1 study recruiting

Treatment Options: none known

Strategies to Preserve Eye Health: 

Institution(s) Conducting Research: Sanford Health
Sioux Falls (U.S.) | Online Patient Enrollment System (Australia) | UMC Utrecht

 

A FACE OF RP

Image by Erik Mclean

tbd

tbd

IN THE NEWS

ACADEMIC PAPERS | JOURNAL ARTICLES | PERSONAL STORIES

CRB1 mutations in inherited retinal dystrophies

Mutations in the CLRN1 gene cause Usher syndrome type 3 (USH3), a human disease characterized by progressive blindness and deafness. Clarin 1, the protein product of CLRN1, is a four-transmembrane protein predicted to be associated with ribbon synapses of photoreceptors and cochlear hair cells, and recently demonstrated to be associated with the cytoskeleton. 

Research Models and Gene Augmentation Therapy for CRB1 Retinal Dystrophies

Nanda Boon, Jan Wijnholds, and Lucie P. Pellissier | Frontier Neuroscience | 2020 Aug 14 | 

doi.org/10.3389/fnins.2020.00860

In this review, we will discuss the recent advances, advantages and disadvantages of different CRB1 human and animal retinal degeneration models. In addition, we will describe novel therapeutic tools that have been developed, which could potentially be used for retinal gene augmentation therapy for RP patients with variations in the CRB1 gene.

ADD NEW ARTICLE

Update

Update

Read

ADD NEW ARTICLE

Read
bottom of page